Immune Response to Human Papillomaviruses and the Prospects for Human Papillomavirus-Specific Immunisation
- 1 January 1994
- book chapter
- Published by Springer Nature
- Vol. 186, 217-253
- https://doi.org/10.1007/978-3-642-78487-3_12
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Multiple levels of peripheral toleranceImmunology Today, 1993
- Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7European Journal Of Cancer, 1992
- Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.The Journal of Experimental Medicine, 1992
- Seroreactivity to HPV-16 proteins in women with early cervical neoplasiaCancer Immunology, Immunotherapy, 1992
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991
- Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.The Journal of Experimental Medicine, 1990
- Occurrence of Langerhans cells and expression of class II antigens on keratinocytes in malignant and benign epithelial tumors of the skin: An immunohistopathologic study with monoclonal antibodiesJournal of the American Academy of Dermatology, 1989
- Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferonJournal of the American Academy of Dermatology, 1984
- Versuche Über Immuntherapie der Warzen und KondylomeJournal of Molecular Medicine, 1925